A clinician's guide to psychosocial functioning and quality of life in bipolar disorder

Practical Management of Bipolar Disorder

Volumn , Issue , 2010, Pages 163-174

  Michalak, Erin E ^a   Murray, Greg ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955054994     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511776922.016     Document Type: Chapter

References (69)

1. Altshuler, L.L., Post, R.M., Black, D.O., et al. (2006). Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. Journal of Clinical Psychiatry, 67, 1551–60.
2. Arnold, L.M., Witzeman, K.A., Swank, M.L., McElroy, S.L., Keck Jr, P.E. (2000). Health-related quality of life using the SF-36 in patients with bipolar disorder compared with patients with chronic back pain and the general population. Journal of Affective Disorders, 57, 235–9.
3. Atkinson, M., Zibin, S., Chuang, H. (1997). Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. American Journal of Psychiatry, 154, 99–105.
4. Bechdolf, A., Pukrop, R., Kohn, D., et al. (2005). Subjective quality of life in subjects at risk for a fi rst episode of psychosis: a comparison with fi rst episode schizophrenia patients and healthy controls. Schizophrenia Research, 79, 137–43.
5. Calabrese, J.R., Keck Jr, P.E., Macfadden, W., et al. (2005). A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. American Journal of Psychiatry, 162, 1351–60.
6. Chand, P.K., Mattoo, S.K., Sharan, P. (2004). Quality of life and its correlates in patients with bipolar disorder stabilized on lithium prophylaxis. Psychiatry and Clinical Neurosciences, 58, 311–18.
7. Coons, S.J., Rao, S., Keininger, D.L., Hays, R.D. (2000). A comparative review of generic quality-of-life instruments. Pharmacoeconomics, 17, 13–35.
8. Dean, B.B., Gerner, D., Gerner, R.H. (2004). A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder. Current Medical Research and Opinion, 20, 139–54.
9. Dickerson, F.B., Boronow, J.J., Stallings, C.R., Origoni, A.E., Cole, S., Yolken, R.H. (2004). Association between cognitive functioning and employment status of persons with bipolar disorder. Psychiatric Services (Washington, D.C.), 55, 54–8.
10. Dion, G.L., Tohen, M., Anthony, W.A., Waternaux, C.S. (1988). Symptoms and functioning of patients with bipolar disorder six months aft er hospitalization. Hospital & Community Psychiatry, 39, 652–7.
11. Dogan, S. & Sabanciogullari, S. (2003). The effects of patient education in lithium therapy on quality of life and compliance. Archives of Psychiatric Nursing, 17, 270–5.
12. Endicott, J., Nee, J., Harrison, W., Blumenthal, R. (1993). Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacology Bulletin, 29, 321–6.
13. Endicott, J., Rajagopalan, K., Minkwitz, M., Macfadden, W. (2007). A randomized, double-blind, placebocontrolled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life. International Clinical Psychopharmacology, 22, 29–37.
14. Endicott, J., Spitzer, R.L., Fleiss, J.L., Cohen, J. (1976). The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry, 33, 766–71.
15. Frank, E., Swartz, H.A., Kupfer, D.J. (2000). Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder [In Process Citation]. Biological Psychiatry, 48, 593–604.
16. Goldberg, J.F. & Harrow, M. (2005). Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis. Journal of Affective Disorders, 89, 79–89.
17. Goldberg, J.F., Harrow, M., Grossman, L.S. (1995). Course and outcome in bipolar affective disorder: a longitudinal follow-up study. American Journal of Psychiatry, 152, 379–84.
18. Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76–338. Rockville, MD: US Department of Health, Education and Welfare.
19. Hammen, C. & Cohen, A.N. (2004). Psychosocial functioning. In: Johnson, S.L. & Leahy, R.L. (E ds). Psychological Treatment of Bipolar Disorder. New York: The Guilford Press, pp. 17–34.
20. Hammen, C., Gitlin, M., Altshuler, L. (2000). Predictors of work adjustment in bipolar I patients: a naturalistic longitudinal follow-up. Journal of Consulting and Clinical Psychology, 68, 220–5.
21. Harrow, M., Goldberg, J.F., Grossman, L.S., Meltzer, H.Y. (1990). Outcome in manic disorders. A naturalistic follow-up study. Archives of General Psychiatry, 47, 665–71.
22. Jaeger, J., Berns, S.M., Czobor, P. (2003). The multidimensional scale of independent functioning: a new instrument for measuring functional disability in psychiatric populations. Schizophrenia Bulletin, 29, 153–68.
23. Judd, L.L., Akiskal, H.S., Schettler, P.J., et al. (2002). The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry, 59, 530–7.
24. Judd, L.L., Akiskal, H.S., Schettler, P.J., et al. (2003). A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Archives of General Psychiatry, 60, 261–9.
25. Keck Jr, P.E. (2004). Defi ning and improving response to treatment in patients with bipolar disorder. Journal of Clinical Psychiatry, 65 (Suppl. 15), 25–9.
26. Kocsis, J.H., Zisook, S., Davidson, J., et al. (1997). Doubleblind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. American Journal of Psychiatry, 154, 390–5.
27. Kolotkin, R.L., Corey-Lisle, P.K., Crosby, R.D., et al. (2008). Impact of obesity on health-related quality of life in schizophrenia and bipolar disorder. Obesity (Silver Spring, Md.), 16, 749–54.
28. Kusznir, A., Scott, E., Cooke, R.G., Young, L.T. (1996). Functional consequences of bipolar affective disorder: an occupational therapy perspective. Canadian Journal of Occupational Therapy, 63, 313–22.
29. Leverich, G.S., Nolen, W.A., Rush, A.J., et al. (2001). The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. Journal of Affective Disorders, 67, 33–44.
30. Loft us, S.T. & Jaeger, J. (2006). Psychosocial outcome in bipolar I patients with a personality disorder. Journal of Nervous and Mental Disease, 194, 967–70.
31. MacQueen, G.M., Young, L.T., Joffe, R.T. (2001). A review of psychosocial outcome in patients with bipolar disorder. Acta Psychiatrica Scandinavica, 103, 163–70.
32. Maina, G., Albert, U., Bellodi, L., et al. (2007). Healthrelated quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. Journal of Clinical Psychiatry, 68, 207–12.
33. Michalak, E.E. & Murray, G.W. (2008). Using quality of life as an outcome measure in patients with bipolar disorder. Aspects of Affect, 2.
34. Michalak, E.E., Murray, G., Young, A., Lam, R.W. (2007a). Quality of life impairment in bipolar disorder. In: Ritsner M. & Awad A.G. (Eds). Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders. New Perspectives on Research and Treatment. Dordrechht, The Netherlands: Springer, pp. 253–74.
35. Michalak, E.E., Murray, G., Young, A.H., Lam, R.W. (2008). Burden of bipolar depression: impact of disorder and medications on quality of life. CNS Drugs, 22, 389–406.
36. Michalak, E.E., Yatham, L.N., Kolesar, S., Lam, R.W. (2006). Bipolar disorder and quality of life: a patient-centered perspective. Quality of Life Research, 15, 25–37.
37. Michalak, E.E., Yatham, L.N., Lam, R.W. (2005a). Quality of life in bipolar disorder: a review of the literature. Health and Quality of Life Outcomes, 3, 72.
38. Michalak, E.E., Yatham, L.N., Maxwell, V., Hale, S., Lam, R.W. (2007b). The impact of bipolar disorder upon work functioning: a qualitative analysis. BipolarDisorders, 9, 126–43.
39. Michalak, E.E., Yatham, L.N., Wan, D.D., Lam, R.W. (2005b). Perceived quality of life in patients with bipolar disorder. Does group psychoeducation have an impact? Canadian Journal of Psychiatry, 50, 95–100.
40. Miklowitz, D.J. & Goldstein, M.J. (1997). Bipolar Disorder: A Family-focused Treatment Approach, New York: Guilford Press.
41. Miklowitz, D.J., Goldstein, M.J., Nuechterlein, K.H., Snyder, K.S., Mintz, J. (1988). Family factors and the course of bipolar affective disorder. Archives of General Psychiatry, 45, 225–31.
42. Miller, I.W., Keitner, G.I., Schatzberg, A.F., et al. (1998). The treatment of chronic depression, part 3: psychosocial functioning before and aft er treatment with sertraline or imipramine. Journal of Clinical Psychiatry, 59, 608–19.
43. Namjoshi, M.A. & Buesching, D.P. (2001). A review of the health-related quality of life literature in bipolar disorder. Quality of Life Research, 10, 105–15.
44. Namjoshi, M.A., Rajamannar, G., Jacobs, T., et al. (2002). Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled. Journal of Affective Disorders, 69, 109–18.
45. Namjoshi, M.A., Risser, R., Shi, L., Tohen, M., Breier, A. (2004). Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid. Journal of Affective Disorders, 81, 223–9.
46. Niv, N., Cohen, A.N., Sullivan, G., Young, A.S. (2007). The MIRECC version of the Global Assessment of Functioning scale: reliability and validity. Psychiatric services (Washington, D.C.), 58, 529–35.
47. Otto, M.W., Reilly-Harrington, N., Sachs, G.S. (2003). Psychoeducational and cognitive-behavioral strategies in the management of bipolar disorder. Journal of Affective Disorders, 73, 171–81.
48. Patelis-Siotis, I., Young, L.T., Robb, J.C., et al. (2001). Group cognitive behavioral therapy for bipolar disorder: a feasibility and effectiveness study. Journal of Affective Disorders, 65, 145–53.
49. Post, R.M., Denicoff, K.D., Leverich, G.S., et al. (2003a). Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. Journal of Clinical Psychiatry, 64, 680–90.
50. Post, R.M., Leverich, G.S., Altshuler, L.L., et al. (2003b). An overview of recent fi ndings of the Stanley Foundation Bipolar Network (Part I). Bipolar Disorders, 5, 310–19.
51. Post, R.M., Nolen, W.A., Kupka, R.W., et al. (2001). The Stanley Foundation Bipolar Network. I. Rationale and methods. British Journal of Psychiatry, Supplement, 41, S169– 76.
52. Revicki, D.A., Matza, L.S., Flood, E., Lloyd, A. (2005). Bipolar disorder and health-related quality of life: review of burden of disease and clinical trials. Pharmacoeconomics, 23, 583–94.
53. Revicki, D.A., Paramore, L.C., Sommerville, K.W., Swann, A.C., Zajecka, J.M. (2003). Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes. Journal of Clinical Psychiatry, 64, 288–94.
54. Rosa, A.R., Sanchez-Moreno, J., Martinez-Aran, A., et al. (2007). Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clinical Practice and Epidemiology in Mental Health, 3, 5.
55. Ruggero, C.J., Chelminski, I., Young, D., Zimmerman, M. (2007). Psychosocial impairment associated with bipolar II disorder. Journal of Affective Disorders, 104, 53–60.
56. Shi, L., Namjoshi, M.A., Swindle, R., et al. (2004). Effects of olanzapine alone and olanzapine/fl uoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial. Clinical Therapeutics, 26, 125–34.
57. Shi, L., Namjoshi, M.A., Zhang, F., et al. (2002). Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. International Clinical Psychopharmacology, 17, 227–37.
58. ten Have, M., Vollebergh, W., Bijl, R., Nolen, W.A. (2002). Bipolar disorder in the general population in The Netherlands (prevalence, consequences and care utilisation): results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Journal of Affective Disorders, 68, 203–13.
59. The WHOQOL Group (1995). The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Social Science & Medicine, 41, 1403–9.
60. Tohen, M., Goldberg, J.F., Gonzalez-Pinto Arrillaga, A.M., et al. (2003). A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Archives of General Psychiatry, 60, 1218–26.
61. Tohen, M., Hennen, J., Zarate Jr, C.M., et al. (2000). Twoyear syndromal and functional recovery in 219 cases of fi rst-episode major affective disorder with psychotic features. American Journal of Psychiatry, 157, 220–8.
62. Tohen, M., Waternaux, C.M., Tsuang, M.T. (1990). Outcome in mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis. Archives of General Psychiatry, 47, 1106–11.
63. Tryssenaar, J. (1998). Vocational exploration and employment and psychosocial disabilities. In: Psychosocial Occupational Therapy: A Holistic Approach. San Diego, CA: Singular Publishing Group, pp. 351–73.
64. Tse, S. & Yeats, M. (2002). What helps people with bipolar affective disorder succeed in employment: a grounded theory approach. Work, 19, 47–62.
65. Vojta, C., Kinosian, B., Glick, H., Altshuler, L., Bauer, M.S. (2001). Self-reported quality of life across mood states in bipolar disorder. Comprehensive Psychiatry, 42, 190–5.
66. Ware, J. E., Snow, K.K., Kosinski, M., Gandek, B. (1993). SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute.
67. Weinstock, L.M. & Miller, I.W. (2008). Functional impairment as a predictor of short-term symptom course in bipolar I disorder. Bipolar Disorders, 10, 437–42.
68. Yatham, L.N., Lecrubier, Y., Fieve, R.R., Davis, K.H., Harris, S.D., Krishnan, A.A. (2004). Quality of life in patients with bipolar I depression: data from 920 patients. Bipolar Disorders, 6, 379–85.
69. Zhang, H., Wisniewski, S.R., Bauer, M.S., Sachs, G.S., Thase, M.E. (2006). Comparisons of perceived quality of life across clinical states in bipolar disorder: data from the fi rst 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants. Comprehensive Psychiatry, 47, 161–8.